-
-
-
-
-
-
-
MoonLake reports positive Phase 2 results for axial spondyloarthritis drug
-
-
-
-
-
-
-
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update
-
-
-
-
-
-
-
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10
-
-
-
-
-
-
-
MoonLake Immunotherapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides a Business Update
-
-
1,199,636 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

